Candidate Surrogate End Points for ESRD after AKI

Overview of attention for article published in Journal of the American Society of Nephrology, February 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 10 X posts from 8 X users, with an upper bound of 70,970 followers.

30-40% eGFR decline post #AKI could be surrogate endpoint for #ESRD in AKI prevention trials https://t.co/OBntucGjzZ @NatRevNeph @JASN_News

RT @NatRevNeph: New in @JASN_News: 30-40% decline in eGFR post AKI could be surrogate end point for ESRD in trials of AKI prevention https:…

New in @JASN_News: 30-40% decline in eGFR post AKI could be surrogate end point for ESRD in trials of AKI prevention https://t.co/adxrOgZTha

RT @Thomas_Hiemstra: #Trial endpoints in AKI - 30% reduction in EGFR at 30, 60 or 90 days https://t.co/3h763Seed0

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.